IN THE HIGH COURT OF DELHI AT NEW DELHI
C. HARI SHANKAR, J.
Dr. Reddys Laboratories Limited - Plaintiff
Versus
Ridgecure Pharma - Defendant
CS(COMM) No.5 of 2021 and I.A. No.106 of 2021 (Order XXXIX Rules 1 and 2 of the CPC)
Decided On : 30-01-2023
Survives for adjudication - Dispute in this suit stands settled between parties vide Settlement Agreement executed under aegis of Delhi High Court Mediation and Conciliation Centre - Copy of agreement has been placed on record - Learned Counsel for plaintiff and defendant are present in Court - Held, Learned Counsels agree on behalf of their respective clients, to abide by aforesaid terms of Settlement Agreement - Accordingly, terms of settlement shall be binding on both parties - In view thereof, nothing survives for adjudication in present case - Suit, accordingly, stands decreed, in terms of aforesaid terms of settlement as contained in Settlement Agreement - Disposed of.
JUDGMENT :
1. The dispute in this suit stands settled between the parties vide Settlement Agreement dated 17th January 2023 executed under the aegis of the Delhi High Court Mediation and Conciliation Centre. A copy of the agreement has been placed on record. Learned Counsel for the plaintiff and the defendant are present in Court.
2. The terms of the settlement, as set out in the aforesaid Settlement Agreement, read thus :
2. The Second Party, their directors, confirm and undertake that they have stopped manufacturing, exporting, and offering for sale, advertising, directly or indirectly medicinal and pharmaceutical preparations not limited to tablets, capsules, injections, syrups under the mark OMEZ both for domestic sale in India and for export. The Second Party confirms that the last batch of OMEZ products manufactured and exported by them were as per details below :
| S. No. | Manufacturing month and year | Batch No. | Month of Expiry |
| 1. | July 2020 (OMEZ-D) | TLC-287 | 08/2021 |
| 2. | May 2020 (OMEZ-20) | TLC-153 | 04/2021 |
3. The Second Party agrees to forthwith Cease and desist from manufacturing and marketing of OMEZ product. The Second Party agrees not to adopt at any time in future or use any mark deceptively similar to OMEZ or containing OMEZ in any manner for any pharmaceuticals or medicinal preparations. Any violation of this undertaking making the Second Party liable for exemplary damages and cost of INR 25 Lacs (Twenty-Five Lacs only).
4. The Second Party undertakes and confirms that no fresh batch of OMEZ will be or cause to be made by them. The Second Party declares and confirms that any further production or sale through any route or through a third party will make them liable for claim of cost and damages as set out in clause 3 above.
5. The Second Party confirms that it has not applied for its registration for the mark OMEZ in class 5 and shall not to do so in future.
6. The Second Party undertakes not to adopt any mark in future whether for sale in domestic market or for export any mark that is identical or deceptively similar to the First Party's mark OMEZ or carry out any such activities as may be likely to cause confusion or deception amounting to, passing off their goods under captioned Trademark as and for that of the First Party.
7. The Second Party agrees to remove all the listings of the impugned mark OMEZ if any, from their websites, B2B websites or any other online directories, B2C websites or portals that were used by the Second Party to promote their products bearing the mark OMEZ or any other marks identical or deceptively similar to the First Party's marks “OMEZ”.
8. That both the parties confirm and understand that in case of any violation of the terms of the Settlement terms as set out above them shall be liable for legal proceedings.
9. That the Second Party has agreed to pay a sum of Rs.4,00,000 (Four Lacs only) to the First Party in two installments. The first installment of Rs.3,00,000 to be paid at the time of recording the settlement, by way of demand draft as part of the contribution towards cost. The Second installment of Rs. 1 Lac shall be paid by way of post-dated check bearing the date 1st Jan, 2023 to be handed over at the time of recording the settlement.
10. That in view of the aforesaid undertaking given by the Second Party, the First Party agrees to forego it
The main legal point established in the judgment is the binding nature of a settlement agreement reached between parties, which can lead to the court decreeing the suit in terms of the settlement and....
Settlement agreements can be used to resolve disputes without delving into the merits of the case, and the court may decree the suit in terms of the settlement agreement.
The court's decision was based on the validity and acceptance of the settlement agreement by the parties involved.
The central legal point established in the judgment is the effectiveness of a settlement agreement in resolving a trademark infringement dispute and leading to a decree in favor of the aggrieved part....
The central legal point established in the judgment is the approval and enforcement of a Settlement Agreement to resolve trademark infringement disputes.
Enforcement of Settlement Agreement
Settlement agreements reached through mediation can be decreed by the court, and parties are bound by the terms of the agreement, with defaulting parties being held liable for contempt of court.
Settlement agreements can effectively resolve disputes in trademark infringement cases, allowing parties to acknowledge rights and agree on actions to prevent future violations.
Enforcement of Settlement Agreement
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.